A detailed history of Dowling & Yahnke LLC transactions in Biogen Inc. stock. As of the latest transaction made, Dowling & Yahnke LLC holds 3,717 shares of BIIB stock, worth $645,977. This represents 0.46% of its overall portfolio holdings.

Number of Shares
3,717
Previous 4,118 9.74%
Holding current value
$645,977
Previous $840,000 18.1%
% of portfolio
0.46%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$194.69 - $268.46 $78,070 - $107,652
-401 Reduced 9.74%
3,717 $992,000
Q2 2022

Aug 10, 2022

SELL
$187.54 - $223.02 $173,286 - $206,070
-924 Reduced 18.33%
4,118 $840,000
Q1 2022

May 04, 2022

SELL
$193.77 - $244.14 $186,600 - $235,106
-963 Reduced 16.04%
5,042 $1.06 Million
Q4 2021

Feb 10, 2022

SELL
$223.92 - $287.77 $125,171 - $160,863
-559 Reduced 8.52%
6,005 $1.44 Million
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $82,067 - $107,024
-290 Reduced 4.23%
6,564 $1.86 Million
Q2 2021

Jul 21, 2021

SELL
$259.0 - $414.71 $13,209 - $21,150
-51 Reduced 0.74%
6,854 $2.37 Million
Q1 2021

Apr 29, 2021

SELL
$242.95 - $284.63 $41,301 - $48,387
-170 Reduced 2.4%
6,905 $1.93 Million
Q4 2020

Jan 28, 2021

SELL
$236.26 - $355.63 $52,449 - $78,949
-222 Reduced 3.04%
7,075 $1.73 Million
Q3 2020

Oct 19, 2020

SELL
$264.77 - $305.71 $29,124 - $33,628
-110 Reduced 1.49%
7,297 $2.07 Million
Q2 2020

Jul 31, 2020

SELL
$258.66 - $342.55 $19,399 - $25,691
-75 Reduced 1.0%
7,407 $1.98 Million
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $26,078 - $33,080
97 Added 1.31%
7,482 $2.37 Million
Q4 2019

Jan 27, 2020

BUY
$220.06 - $304.07 $74,380 - $102,775
338 Added 4.8%
7,385 $2.19 Million
Q3 2019

Oct 29, 2019

SELL
$217.44 - $243.88 $28,484 - $31,948
-131 Reduced 1.83%
7,047 $1.64 Million
Q2 2019

Jul 22, 2019

SELL
$219.29 - $241.72 $309,856 - $341,550
-1,413 Reduced 16.45%
7,178 $1.68 Million
Q1 2019

Apr 30, 2019

BUY
$216.71 - $338.96 $128,292 - $200,664
592 Added 7.4%
8,591 $2.03 Million
Q4 2018

Jan 24, 2019

BUY
$278.5 - $352.75 $27,014 - $34,216
97 Added 1.23%
7,999 $2.67 Million
Q3 2018

Oct 30, 2018

BUY
$293.51 - $383.83 $880 - $1,151
3 Added 0.04%
7,902 $2.79 Million
Q2 2018

Jul 30, 2018

BUY
$257.52 - $306.91 $104,553 - $124,605
406 Added 5.42%
7,899 $2.29 Million
Q1 2018

May 01, 2018

BUY
$260.13 - $367.91 $46,303 - $65,487
178 Added 2.43%
7,493 $2.05 Million
Q4 2017

Feb 02, 2018

SELL
$307.64 - $344.58 $2.21 Million - $2.47 Million
-7,182 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$281.15 - $329.69 $2.02 Million - $2.37 Million
7,182
7,182 $2.25 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Dowling & Yahnke LLC Portfolio

Follow Dowling & Yahnke LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.